MétaCan
Menu
← Back to cohort
Record W7014681365

Predictors of SARS-CoV-2 anti-spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the CHILD COVID-19 Add-On Study

2023· dissertation· en· W7014681365 on OpenAlexaboutno aff

Bibliographic record

VenueMspace (University of Manitoba) · 2023
Typedissertation
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsnot available
Fundersnot available
KeywordsVaccinationAntibodyImmune systemAntibody responseImmunoglobulin GYoung adultImmunity
DOInot available

Abstract

fetched live from OpenAlex

Vaccination remains the most effective way to prevent SARS-CoV-2 infection or severe outcomes following infection. However, COVID-19 vaccine-induced humoral immune responses vary among individuals and wane over time. The variation and timing of this immune response is not fully understood, particularly in children. This research aims to 1) describe the SARS-CoV-2 anti-spike IgG antibody response to vaccination and 2) identify the health and demographic factors associated with this response among double-vaccinated children and adults in the Canadian CHILD Cohort. This study included a subset of children (n= 153; mean age: 12 ±1.5 years, 46% female) and adults (n= 978; 44 ±6.0 years, 60% female) vaccinated with two doses. Blood samples were collected over two time-points- March 2021 to September 2021 (Phase A) and October 2021 to January 2022 (Phase B) using Dried Blood Spot (DBS) kits. SARS-CoV-2 anti-spike IgG antibody levels were quantified using automated chemiluminescent ELISAs and expressed in scaled luminescence. Demographic, vaccination, and health information were collected via online questionnaires. Associations were determined by linear regression. In our cross-sectional data, we found a seropositivity rate of 95% following two COVID-19 vaccine doses for both children and adults. 14% (n= 157/1131) of participants had evidence of prior COVID-19. In both children and adults, the highest antibody levels were observed around three months post-vaccination and did not differ by biological sex. In a multivariable model, higher antibody levels were associated with: prior SARS-CoV-2 infection (β= 0.21 scaled luminescence units), age <18 years (β= 0.14) and receiving the Moderna mRNA (β= 0.20) or Moderna mRNA and Pfizer BioNTech vaccines (β= 0.20) vs. a combination of Moderna mRNA or Pfizer BioNTech vaccines and AstraZeneca Oxford vaccines. We did not observe any differences in antibody levels between a 3-8 compared to 9–16-week interval between first and second vaccine dose receipt. In summary, we evaluated and characterized the anti-spike IgG antibody response following receipt of two COVID-19 vaccines and found antibody levels to be associated with age, previous SARS-CoV-2 infection, vaccine type, and time since vaccination. Understanding the determinants of vaccine responsiveness is an important research priority that could provide more insights into ways to improve vaccine immunogenicity and efficacy among different population subgroups.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.665
Threshold uncertainty score0.674

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.338
Teacher spread0.299 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueMspace (University of Manitoba)→Same topicSARS-CoV-2 and COVID-19 Research→French-language works237,207→